SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity.

Am J Trop Med Hyg · 2021 · PMC8437179 · PMID 34143752

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

In conclusion, our data show that SARS-CoV-2-specific antibody responses were greater in those with severe symptoms and waned after reaching a peak around 1 month after symptom onset, with a decreasing trend thereafter.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.